Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MANALI PETRO vs TATVA CHINTAN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MANALI PETRO TATVA CHINTAN PHARMA MANALI PETRO/
TATVA CHINTAN PHARMA
 
P/E (TTM) x 76.3 77.0 99.2% View Chart
P/BV x 1.3 5.6 22.6% View Chart
Dividend Yield % 1.0 0.2 600.1%  

Financials

 MANALI PETRO   TATVA CHINTAN PHARMA
EQUITY SHARE DATA
    MANALI PETRO
Mar-23
TATVA CHINTAN PHARMA
Mar-23
MANALI PETRO/
TATVA CHINTAN PHARMA
5-Yr Chart
Click to enlarge
High Rs1502,649 5.6%   
Low Rs571,606 3.5%   
Sales per share (Unadj.) Rs68.7191.1 35.9%  
Earnings per share (Unadj.) Rs2.920.5 14.4%  
Cash flow per share (Unadj.) Rs4.324.8 17.3%  
Dividends per share (Unadj.) Rs0.752.00 37.5%  
Avg Dividend yield %0.70.1 773.7%  
Book value per share (Unadj.) Rs60.7232.2 26.1%  
Shares outstanding (eoy) m172.0022.17 775.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.511.1 13.5%   
Avg P/E ratio x35.0103.7 33.8%  
P/CF ratio (eoy) x24.085.7 28.0%  
Price / Book Value ratio x1.79.2 18.5%  
Dividend payout %25.59.7 261.2%   
Avg Mkt Cap Rs m17,73747,157 37.6%   
No. of employees `000NANA-   
Total wages/salary Rs m547386 141.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m11,8134,236 278.9%  
Other income Rs m23957 415.2%   
Total revenues Rs m12,0524,294 280.7%   
Gross profit Rs m785572 137.3%  
Depreciation Rs m23296 242.5%   
Interest Rs m9286 107.2%   
Profit before tax Rs m700448 156.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m193-7 -2,726.0%   
Profit after tax Rs m507455 111.4%  
Gross profit margin %6.613.5 49.2%  
Effective tax rate %27.6-1.6 -1,744.6%   
Net profit margin %4.310.7 39.9%  
BALANCE SHEET DATA
Current assets Rs m6,7393,136 214.9%   
Current liabilities Rs m1,4732,361 62.4%   
Net working cap to sales %44.618.3 243.9%  
Current ratio x4.61.3 344.5%  
Inventory Days Days83 272.6%  
Debtors Days Days49273 676.9%  
Net fixed assets Rs m6,0024,304 139.5%   
Share capital Rs m860222 388.1%   
"Free" reserves Rs m9,5834,926 194.5%   
Net worth Rs m10,4445,148 202.9%   
Long term debt Rs m042 0.0%   
Total assets Rs m12,7427,439 171.3%  
Interest coverage x8.66.2 138.4%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.90.6 162.8%   
Return on assets %4.77.3 64.7%  
Return on equity %4.98.8 54.9%  
Return on capital %7.610.3 73.7%  
Exports to sales %2.576.2 3.3%   
Imports to sales %7.356.9 12.9%   
Exports (fob) Rs m2953,229 9.1%   
Imports (cif) Rs m8642,409 35.9%   
Fx inflow Rs m2953,229 9.1%   
Fx outflow Rs m8642,409 35.9%   
Net fx Rs m-569820 -69.5%   
CASH FLOW
From Operations Rs m919278 330.7%  
From Investments Rs m-2,657-1,011 262.7%  
From Financial Activity Rs m-643378 -170.1%  
Net Cashflow Rs m-2,332-357 654.2%  

Share Holding

Indian Promoters % 44.9 72.0 62.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.8 16.5 4.9%  
FIIs % 0.8 3.7 21.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 55.1 28.0 197.1%  
Shareholders   188,540 73,730 255.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MANALI PETRO With:   PIDILITE INDUSTRIES    SRF    BALAJI AMINES    YASHO INDUSTRIES    GHCL    


More on MANALI PETRO vs TATVA CHINTAN PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

MANALI PETRO vs TATVA CHINTAN PHARMA Share Price Performance

Period MANALI PETRO TATVA CHINTAN PHARMA S&P BSE OIL & GAS
1-Day -2.08% 0.02% 0.29%
1-Month 33.60% 9.97% 5.62%
1-Year 12.51% -23.68% 60.10%
3-Year CAGR -1.66% -18.73% 25.67%
5-Year CAGR 23.66% -11.70% 13.77%

* Compound Annual Growth Rate

Here are more details on the MANALI PETRO share price and the TATVA CHINTAN PHARMA share price.

Moving on to shareholding structures...

The promoters of MANALI PETRO hold a 44.9% stake in the company. In case of TATVA CHINTAN PHARMA the stake stands at 72.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of MANALI PETRO and the shareholding pattern of TATVA CHINTAN PHARMA.

Finally, a word on dividends...

In the most recent financial year, MANALI PETRO paid a dividend of Rs 0.8 per share. This amounted to a Dividend Payout ratio of 25.5%.

TATVA CHINTAN PHARMA paid Rs 2.0, and its dividend payout ratio stood at 9.7%.

You may visit here to review the dividend history of MANALI PETRO, and the dividend history of TATVA CHINTAN PHARMA.



Today's Market

HCL Tech Q4 Results | Maruti Suzuki Declares Dividend | Top Buzzing Stocks Today HCL Tech Q4 Results | Maruti Suzuki Declares Dividend | Top Buzzing Stocks Today(Pre-Open)

Indian share markets reversed the trend as the session progressed and ended the lower. After starting higher on Friday, equity markets had an anti-climatic end today.